Metropolis Healthcare Limited (NSE:METROPOLIS)
India · Delayed Price · Currency is INR 564.70
-3.25 (-0.57%)
Jul 13, 2026, 3:29 PM IST
Metropolis Healthcare Market Cap
Metropolis Healthcare has a market cap or net worth of 117.75 billion as of July 13, 2026. Its market cap has increased by 31.84% in one year.
Market Cap
117.75B
Enterprise Value
118.16B
Revenue
16.46B
Ranking
n/a
PE Ratio
61.80
Stock Price
564.70
Market Cap Chart
Since April 15, 2019, Metropolis Healthcare's market cap has increased from 48.16B to 117.75B, an increase of 144.49%. That is a compound annual growth rate of 13.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 117.08B | 17.13% |
| Dec 31, 2025 | 99.96B | -6.11% |
| Dec 31, 2024 | 106.46B | 23.85% |
| Dec 29, 2023 | 85.96B | 26.46% |
| Dec 30, 2022 | 67.98B | -61.39% |
| Dec 31, 2021 | 176.07B | 75.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.64T |
| Divi's Laboratories | 1.81T |
| Apollo Hospitals Enterprise | 1.27T |
| Cipla | 1.16T |
| Park Medi World | 123.58B |
| Indegene | 122.24B |
| Marksans Pharma | 122.04B |
| Akums Drugs and Pharmaceuticals | 107.47B |